Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Transfusion

Showing results (781-790 of 15,364) with videos related to

Pageof 1,537
Sort By:
Transfusion|January 22, 2011
Occult hepatitis B virus infection in Thai blood donorsSuda Louisirirotchanakul, Sineenart Oota, Kalayanee Khuponsarb, et al.
Transfusion|February 10, 2011
Distribution of parvovirus B19 DNA in blood compartments and persistence of virus in blood donorsTzong-Hae Lee, Steven H Kleinman, Li Wen, et al.
Transfusion|November 1, 1990
Effect of an 8-hour holding period on in vivo and in vitro properties of red cells and factor VIII content of plasma after collection in a red cell additive systemG Moroff, S Holme, W A Heaton, et al.
Transfusion|August 19, 2009
Emerging infectious disease agents and their potential threat to transfusion safetySusan L Stramer, F Blaine Hollinger, Louis M Katz, et al.
Transfusion|June 25, 2010
Fucose-deficient hematopoietic stem cells have decreased self-renewal and aberrant marrow niche occupancyJay Myers, Yuanshuai Huang, Lebing Wei, et al.
Transfusion|June 18, 2010
Multiple pH measurement during storage may detect bacterially contaminated platelet concentratesLynn M Barker, Oliver Z Nanassy, Michael W Reed, et al.
Transfusion|June 26, 2010
Expanded evaluation of blood donors in the United States for human immunodeficiency virus type 1 non-B subtypes and antiretroviral drug-resistant strains: 2005 through 2007Catherine A Brennan, Julie Yamaguchi, Sushil G Devare, et al.
Transfusion|June 26, 2010
Misleading hepatitis B test results due to intravenous immunoglobulin administration: implications for a clinical trial of rituximab in immune thrombocytopeniaDonald M Arnold, Mark A Crowther, Ralph M Meyer, et al.
Transfusion|June 26, 2010
Relapsing or refractory idiopathic thrombotic thrombocytopenic purpura-hemolytic uremic syndrome: the role of rituximabDomenica Caramazza, Gerlando Quintini, Ignazio Abbene, et al.
Transfusion|June 26, 2010
Granulocyte antibody screening: evaluation of a bead-based assay in comparison with classical methodsPatricia Fromont, Nolwen Prié, Philippe Simon, et al.
Pageof 1,537

Showing results (781-790 of 15,364) with videos related to

Sort By:
Pageof 1,537
Transfusion|January 22, 2011
Occult hepatitis B virus infection in Thai blood donorsSuda Louisirirotchanakul, Sineenart Oota, Kalayanee Khuponsarb, et al.
Transfusion|February 10, 2011
Distribution of parvovirus B19 DNA in blood compartments and persistence of virus in blood donorsTzong-Hae Lee, Steven H Kleinman, Li Wen, et al.
Transfusion|November 1, 1990
Effect of an 8-hour holding period on in vivo and in vitro properties of red cells and factor VIII content of plasma after collection in a red cell additive systemG Moroff, S Holme, W A Heaton, et al.
Transfusion|August 19, 2009
Emerging infectious disease agents and their potential threat to transfusion safetySusan L Stramer, F Blaine Hollinger, Louis M Katz, et al.
Transfusion|June 25, 2010
Fucose-deficient hematopoietic stem cells have decreased self-renewal and aberrant marrow niche occupancyJay Myers, Yuanshuai Huang, Lebing Wei, et al.
Transfusion|June 18, 2010
Multiple pH measurement during storage may detect bacterially contaminated platelet concentratesLynn M Barker, Oliver Z Nanassy, Michael W Reed, et al.
Transfusion|June 26, 2010
Expanded evaluation of blood donors in the United States for human immunodeficiency virus type 1 non-B subtypes and antiretroviral drug-resistant strains: 2005 through 2007Catherine A Brennan, Julie Yamaguchi, Sushil G Devare, et al.
Transfusion|June 26, 2010
Misleading hepatitis B test results due to intravenous immunoglobulin administration: implications for a clinical trial of rituximab in immune thrombocytopeniaDonald M Arnold, Mark A Crowther, Ralph M Meyer, et al.
Transfusion|June 26, 2010
Relapsing or refractory idiopathic thrombotic thrombocytopenic purpura-hemolytic uremic syndrome: the role of rituximabDomenica Caramazza, Gerlando Quintini, Ignazio Abbene, et al.
Transfusion|June 26, 2010
Granulocyte antibody screening: evaluation of a bead-based assay in comparison with classical methodsPatricia Fromont, Nolwen Prié, Philippe Simon, et al.
Pageof 1,537